ID: ALA432106

Max Phase: Preclinical

Molecular Formula: C28H36O7

Molecular Weight: 484.59

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCc1c(OCCCOc2c(C)c(C)c3c(c2C)CCC(C)(C(=O)O)O3)ccc(C(C)=O)c1O

Standard InChI:  InChI=1S/C28H36O7/c1-7-9-22-23(11-10-21(19(5)29)24(22)30)33-14-8-15-34-25-16(2)17(3)26-20(18(25)4)12-13-28(6,35-26)27(31)32/h10-11,30H,7-9,12-15H2,1-6H3,(H,31,32)

Standard InChI Key:  GYAVXQLBLZJDGC-UHFFFAOYSA-N

Associated Targets(Human)

Cysteinyl leukotriene receptor 1147 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cysteinyl leukotriene receptor 1 781 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cavia porcellus 23802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 484.59Molecular Weight (Monoisotopic): 484.2461AlogP: 5.49#Rotatable Bonds: 10
Polar Surface Area: 102.29Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.71CX Basic pKa: CX LogP: 6.82CX LogD: 3.51
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.34Np Likeness Score: 0.80

References

1. Cohen N, Weber G, Banner BL, Lopresti RJ, Schaer B, Focella A, Zenchoff GB, Chiu AM, Todaro L, O'Donnell M..  (1989)  3,4-Dihydro-2H-1-benzopyran-2-carboxylic acids and related compounds as leukotriene antagonists.,  32  (8): [PMID:2547071] [10.1021/jm00128a028]

Source